2024 Q3 Form 10-Q Financial Statement

#000149315224038100 Filed on September 25, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q1 2023 Q1
Revenue $2.540M $4.894M $5.051M
YoY Change 32.09% -3.11% -12.87%
Cost Of Revenue $2.560M $3.999M $3.924M
YoY Change 34.52% 1.91% -17.53%
Gross Profit -$20.00K $895.0K $1.127M
YoY Change -200.0% -20.59% 8.47%
Gross Profit Margin -0.79% 18.29% 22.31%
Selling, General & Admin $787.0K $1.074M $993.0K
YoY Change 10.85% 8.16% 13.49%
% of Gross Profit 120.0% 88.11%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $61.00K $62.00K $80.00K
YoY Change 1.67% -22.5% -18.37%
% of Gross Profit 6.93% 7.1%
Operating Expenses $971.0K $1.248M $1.115M
YoY Change 14.37% 11.93% 5.39%
Operating Profit -$991.0K -$353.0K $12.00K
YoY Change 19.54% -3041.67% -163.16%
Interest Expense -$201.0K -$218.0K $142.0K
YoY Change -262.1% -253.52% 47.92%
% of Operating Profit 1183.33%
Other Income/Expense, Net -$202.0K -$223.0K $384.0K
YoY Change 46.38% -158.07% -19300.0%
Pretax Income -$1.193M -$576.0K $396.0K
YoY Change 23.37% -245.45% -1985.71%
Income Tax
% Of Pretax Income
Net Earnings -$1.193M -$576.0K $23.00M
YoY Change 23.37% -102.5% -109623.81%
Net Earnings / Revenue -46.97% -11.77% 455.36%
Basic Earnings Per Share -$0.05 -$0.03 $0.02
Diluted Earnings Per Share -$0.05 -$0.03 $0.02
COMMON SHARES
Basic Shares Outstanding 25.85M shares 20.77M shares 19.97M shares
Diluted Shares Outstanding 25.85M shares 20.77M shares 17.69M shares

Balance Sheet

Concept 2024 Q3 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.000K $49.00K $130.0K
YoY Change -91.67% -62.31% -37.5%
Cash & Equivalents $5.000K $49.00K $130.0K
Short-Term Investments
Other Short-Term Assets $355.0K $394.0K $489.0K
YoY Change -13.41% -19.43% 103.75%
Inventory $7.852M $7.710M $7.944M
Prepaid Expenses $355.0K $394.0K $489.0K
Receivables $2.196M $4.398M $3.344M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $10.41M $12.55M $11.91M
YoY Change 4.75% 5.41% -7.75%
LONG-TERM ASSETS
Property, Plant & Equipment $5.043M $956.0K $898.0K
YoY Change 495.4% 6.46% -16.54%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.192M
YoY Change
Total Long-Term Assets $10.21M $4.195M $4.655M
YoY Change 135.55% -9.88% -13.04%
TOTAL ASSETS
Total Short-Term Assets $10.41M $12.55M $11.91M
Total Long-Term Assets $10.21M $4.195M $4.655M
Total Assets $20.62M $16.75M $16.56M
YoY Change 44.48% 1.11% -9.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.568M $964.0K $1.278M
YoY Change 12.0% -24.57% -45.55%
Accrued Expenses $525.0K $708.0K $1.382M
YoY Change -57.46% -48.77% 184.95%
Deferred Revenue
YoY Change
Short-Term Debt $4.062M $5.556M $4.284M
YoY Change 20.53% 29.69% -16.94%
Long-Term Debt Due $503.0K $489.0K $1.826M
YoY Change -72.81% -73.22% 697.38%
Total Short-Term Liabilities $7.797M $8.249M $9.288M
YoY Change -6.83% -11.19% 6.53%
LONG-TERM LIABILITIES
Long-Term Debt $467.0K $512.0K $0.00
YoY Change -100.0%
Other Long-Term Liabilities $2.422M $2.707M $3.239M
YoY Change -18.72% -16.42% -14.24%
Total Long-Term Liabilities $2.889M $3.219M $3.239M
YoY Change -2.92% -0.62% -40.9%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.797M $8.249M $9.288M
Total Long-Term Liabilities $2.889M $3.219M $3.239M
Total Liabilities $10.69M $11.47M $12.53M
YoY Change -5.81% -8.45% -11.78%
SHAREHOLDERS EQUITY
Retained Earnings -$26.54M -$24.93M -$23.72M
YoY Change 6.83% 5.1% 4.62%
Common Stock $27.53M $21.28M $27.92M
YoY Change 29.37% -23.77% 49.43%
Preferred Stock
YoY Change
Treasury Stock (at cost) $161.0K $161.0K $161.0K
YoY Change 0.0% 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity $9.933M $5.278M $4.035M
YoY Change
Total Liabilities & Shareholders Equity $20.62M $16.75M $16.56M
YoY Change 44.48% 1.11% -9.3%

Cashflow Statement

Concept 2024 Q3 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$1.193M -$576.0K $23.00M
YoY Change 23.37% -102.5% -109623.81%
Depreciation, Depletion And Amortization $61.00K $62.00K $80.00K
YoY Change 1.67% -22.5% -18.37%
Cash From Operating Activities $754.0K -$767.0K -$1.369M
YoY Change -18.04% -43.97% -68550.0%
INVESTING ACTIVITIES
Capital Expenditures $28.00K $154.0K $56.00K
YoY Change -44.0% 175.0% -473.33%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$28.00K -$154.0K -$56.00K
YoY Change -44.0% 175.0% 273.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $16.00K $45.00K
YoY Change -64.44%
Cash From Financing Activities -743.0K $49.00K $1.409M
YoY Change -18.35% -96.52% 809.03%
NET CHANGE
Cash From Operating Activities 754.0K -$767.0K -$1.369M
Cash From Investing Activities -28.00K -$154.0K -$56.00K
Cash From Financing Activities -743.0K $49.00K $1.409M
Net Change In Cash -17.00K -$872.0K -$16.00K
YoY Change -57.5% 5350.0% -111.27%
FREE CASH FLOW
Cash From Operating Activities $754.0K -$767.0K -$1.369M
Capital Expenditures $28.00K $154.0K $56.00K
Free Cash Flow $726.0K -$921.0K -$1.425M
YoY Change -16.55% -35.37% -8482.35%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 YHGJ Advances From Investors
AdvancesFromInvestors
usd
CY2023Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
usd
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
CY2024Q1 YHGJ Conversion Of Notes And Deposits Into Common Stock
ConversionOfNotesAndDepositsIntoCommonStock
usd
CY2023Q1 YHGJ Reclassification Of Advances Upon Issuances Of Preferred Stock
ReclassificationOfAdvancesUponIssuancesOfPreferredStock
usd
CY2023Q1 YHGJ Allocation Of Proceeds From Preferred Stock Financing To Issuance Of Warrants For Preferred Stock
AllocationOfProceedsFromPreferredStockFinancingToIssuanceOfWarrantsForPreferredStock
usd
CY2024Q1 YHGJ Accrued Deemed Dividends One
AccruedDeemedDividendsOne
usd
CY2024Q1 YHGJ Accrued Deemed Dividends Two
AccruedDeemedDividendsTwo
usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2023Q1 YHGJ Stock Issued During Period Value Convertible Preferred Stock Issuance
StockIssuedDuringPeriodValueConvertiblePreferredStockIssuance
usd
CY2023Q1 YHGJ Accrued Deemed Dividends One
AccruedDeemedDividendsOne
usd
CY2023Q1 YHGJ Accrued Deemed Dividends One
AccruedDeemedDividendsOne
usd
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
000-23115
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
YUNHONG GREEN CTI LTD.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
IL
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
36-2848943
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
22160 N. Pepper Road
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Barrington
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60010
CY2024Q1 dei City Area Code
CityAreaCode
(847)
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
382-1000
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock, no par value per share
CY2024Q1 dei Trading Symbol
TradingSymbol
YHGJ
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25848187 shares
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
921000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3975000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
7791000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
332000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
13019000 usd
CY2023Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
17940000 usd
CY2023Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
2084000 usd
CY2023Q4 YHGJ Intellectual Property Gross
IntellectualPropertyGross
783000 usd
CY2023Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
39000 usd
CY2023Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
519000 usd
CY2023Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
112000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
21477000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20613000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
864000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3364000 usd
CY2024Q1 YHGJ Assets Noncurrent Excluding Property Plant And Equipment
AssetsNoncurrentExcludingPropertyPlantAndEquipment
3239000 usd
CY2024Q1 us-gaap Assets
Assets
16746000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
964000 usd
CY2024Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
5556000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
532000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
708000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
8249000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2707000 usd
CY2024Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
3219000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
11468000 usd
CY2024Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20815595 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20771937 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
21283000 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7889000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-24933000 usd
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
43658 shares
CY2024Q1 us-gaap Treasury Stock Value
TreasuryStockValue
161000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
5278000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16746000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4894000 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3999000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3924000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
895000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
1127000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1040000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
961000 usd
CY2024Q1 us-gaap Selling Expense
SellingExpense
34000 usd
CY2023Q1 us-gaap Selling Expense
SellingExpense
32000 usd
CY2024Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
174000 usd
CY2023Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
122000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
1248000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
1115000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-353000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
12000 usd
CY2024Q1 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
218000 usd
CY2023Q1 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
142000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
526000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-223000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
384000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-576000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
396000 usd
CY2024Q1 YHGJ Deemed Dividends On Preferred Stock And Amortization Of Beneficial Conversion Feature
DeemedDividendsOnPreferredStockAndAmortizationOfBeneficialConversionFeature
14000 usd
CY2023Q1 YHGJ Deemed Dividends On Preferred Stock And Amortization Of Beneficial Conversion Feature
DeemedDividendsOnPreferredStockAndAmortizationOfBeneficialConversionFeature
11000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-590000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
385000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20771937 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17689552 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20771937 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17689552 shares
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
62000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
80000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
122000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
423000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1726000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-81000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-381000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
62000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
100000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
47000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-35000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-18000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-372000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-767000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1369000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
154000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
56000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-154000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-56000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
500000 usd
CY2024Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1000000 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
16000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
45000 usd
CY2024Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
565000 usd
CY2023Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
1454000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
49000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1409000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-872000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-16000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
921000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
146000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
49000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
130000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
218000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
118000 usd
CY2024Q1 YHGJ Accretion Of Dividends On Preferred Stock
AccretionOfDividendsOnPreferredStock
14000 usd
CY2023Q1 YHGJ Accretion Of Dividends On Preferred Stock
AccretionOfDividendsOnPreferredStock
11000 usd
CY2023Q1 YHGJ Conversion Of Notes And Deposits Into Common Stock
ConversionOfNotesAndDepositsIntoCommonStock
885000 usd
CY2024Q1 YHGJ Reclassification Of Advances Upon Issuances Of Preferred Stock
ReclassificationOfAdvancesUponIssuancesOfPreferredStock
1500000 usd
CY2024Q1 YHGJ Allocation Of Proceeds From Preferred Stock Financing To Issuance Of Warrants For Preferred Stock
AllocationOfProceedsFromPreferredStockFinancingToIssuanceOfWarrantsForPreferredStock
814000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
3732000 usd
CY2024Q1 YHGJ Stock Issued During Period Value New Issues One
StockIssuedDuringPeriodValueNewIssuesOne
1300000 usd
CY2024Q1 YHGJ Stock Issued During Period Value New Issues Two
StockIssuedDuringPeriodValueNewIssuesTwo
700000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
122000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-576000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
5278000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2746000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2746000 usd
CY2023Q1 YHGJ Common Stock Issued For Notes Payable And Investor Deposit Value
CommonStockIssuedForNotesPayableAndInvestorDepositValue
884000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
9000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
396000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
4035000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
4035000 usd
CY2024Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_84C_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zb6zQI1SwZG4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_z2EMbJx8QNk5">Reclassification</span>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain amounts in the Company’s condensed consolidated financial statements for prior periods have been reclassified to conform to the current period presentation. These reclassifications have not changed the results of operations of prior periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_843_eus-gaap--UseOfEstimates_zVik7sKXnKcd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zVCvDilbFE67">Use of estimates</span>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management makes estimates and assumptions that affect the amounts reported of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period in the financial statements and accompanying notes. Actual results may differ from those estimates. The Company’s significant estimates include valuation allowances for credit losses and inventory valuation, and the valuation of warrants to purchase preferred stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
556000 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
128000 shares
us-gaap Profit Loss
ProfitLoss
25000000 usd
CY2022Q4 us-gaap Payments For Rent
PaymentsForRent
172000 usd
CY2022Q4 us-gaap Debt Conversion Original Debt Interest Rate Of Debt
DebtConversionOriginalDebtInterestRateOfDebt
0.03 pure
CY2023Q1 YHGJ Common Stock Rate Percentage
CommonStockRatePercentage
0.84 pure
CY2023Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
900000 usd
CY2023Q1 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
1800000 shares
CY2021Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
128.00 shares
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
317000 usd
CY2023Q4 YHGJ Conversion Price Percentage
ConversionPricePercentage
0.84 pure
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.68 pure
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
2.41 pure
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0555 pure
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2024Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
556000 shares
CY2024Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
1225000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1156000 usd
CY2024Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
2501000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2511000 usd
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3894000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4124000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
7710000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
7791000 usd
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
35000 usd

Files In Submission

Name View Source Status
0001493152-24-038100-index-headers.html Edgar Link pending
0001493152-24-038100-index.html Edgar Link pending
0001493152-24-038100.txt Edgar Link pending
0001493152-24-038100-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
yhgj-20240331.xsd Edgar Link pending
yhgj-20240331_lab.xml Edgar Link unprocessable
yhgj-20240331_cal.xml Edgar Link unprocessable
yhgj-20240331_def.xml Edgar Link unprocessable
yhgj-20240331_pre.xml Edgar Link unprocessable